730 related articles for article (PubMed ID: 15910549)
41. Copper enhances APP dimerization and promotes Aβ production.
Noda Y; Asada M; Kubota M; Maesako M; Watanabe K; Uemura M; Kihara T; Shimohama S; Takahashi R; Kinoshita A; Uemura K
Neurosci Lett; 2013 Jun; 547():10-5. PubMed ID: 23669644
[TBL] [Abstract][Full Text] [Related]
42. Nardilysin prevents amyloid plaque formation by enhancing α-secretase activity in an Alzheimer's disease mouse model.
Ohno M; Hiraoka Y; Lichtenthaler SF; Nishi K; Saijo S; Matsuoka T; Tomimoto H; Araki W; Takahashi R; Kita T; Kimura T; Nishi E
Neurobiol Aging; 2014 Jan; 35(1):213-22. PubMed ID: 23954170
[TBL] [Abstract][Full Text] [Related]
43. Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.
Cherny RA; Atwood CS; Xilinas ME; Gray DN; Jones WD; McLean CA; Barnham KJ; Volitakis I; Fraser FW; Kim Y; Huang X; Goldstein LE; Moir RD; Lim JT; Beyreuther K; Zheng H; Tanzi RE; Masters CL; Bush AI
Neuron; 2001 Jun; 30(3):665-76. PubMed ID: 11430801
[TBL] [Abstract][Full Text] [Related]
44. Zinc takes the center stage: its paradoxical role in Alzheimer's disease.
Cuajungco MP; Fagét KY
Brain Res Brain Res Rev; 2003 Jan; 41(1):44-56. PubMed ID: 12505647
[TBL] [Abstract][Full Text] [Related]
45. Pro-oxidant diet enhances β/γ secretase-mediated APP processing in APP/PS1 transgenic mice.
Choudhry F; Howlett DR; Richardson JC; Francis PT; Williams RJ
Neurobiol Aging; 2012 May; 33(5):960-8. PubMed ID: 20724034
[TBL] [Abstract][Full Text] [Related]
46. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
[TBL] [Abstract][Full Text] [Related]
47. Chronic exposure to high levels of zinc or copper has little effect on brain metal homeostasis or Abeta accumulation in transgenic APP-C100 mice.
Maynard CJ; Cappai R; Volitakis I; Laughton KM; Masters CL; Bush AI; Li QX
Cell Mol Neurobiol; 2009 Jul; 29(5):757-67. PubMed ID: 19381799
[TBL] [Abstract][Full Text] [Related]
48. A copper-binding site in the cytoplasmic domain of BACE1 identifies a possible link to metal homoeostasis and oxidative stress in Alzheimer's disease.
Dingwall C
Biochem Soc Trans; 2007 Jun; 35(Pt 3):571-3. PubMed ID: 17511654
[TBL] [Abstract][Full Text] [Related]
49. Role of synaptic activity in the regulation of amyloid beta levels in Alzheimer's disease.
Cheng X; Wu J; Geng M; Xiong J
Neurobiol Aging; 2014 Jun; 35(6):1217-32. PubMed ID: 24368087
[TBL] [Abstract][Full Text] [Related]
50. Role of amyloid beta in lipid homeostasis.
Grösgen S; Grimm MO; Friess P; Hartmann T
Biochim Biophys Acta; 2010 Aug; 1801(8):966-74. PubMed ID: 20452461
[TBL] [Abstract][Full Text] [Related]
51. Copper(I) and copper(II) inhibit Aβ peptides proteolysis by insulin-degrading enzyme differently: implications for metallostasis alteration in Alzheimer's disease.
Grasso G; Pietropaolo A; Spoto G; Pappalardo G; Tundo GR; Ciaccio C; Coletta M; Rizzarelli E
Chemistry; 2011 Feb; 17(9):2752-62. PubMed ID: 21274957
[TBL] [Abstract][Full Text] [Related]
52. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
Bi Oh S; Suh N; Kim I; Lee JY
Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795
[TBL] [Abstract][Full Text] [Related]
53. Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Abeta production in APP23 transgenic mice.
Bayer TA; Schäfer S; Simons A; Kemmling A; Kamer T; Tepest R; Eckert A; Schüssel K; Eikenberg O; Sturchler-Pierrat C; Abramowski D; Staufenbiel M; Multhaup G
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14187-92. PubMed ID: 14617773
[TBL] [Abstract][Full Text] [Related]
54. Metallostasis in Alzheimer's disease.
Ayton S; Lei P; Bush AI
Free Radic Biol Med; 2013 Sep; 62():76-89. PubMed ID: 23142767
[TBL] [Abstract][Full Text] [Related]
55. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression.
Manczak M; Anekonda TS; Henson E; Park BS; Quinn J; Reddy PH
Hum Mol Genet; 2006 May; 15(9):1437-49. PubMed ID: 16551656
[TBL] [Abstract][Full Text] [Related]
56. Alzheimer's disease and amyloid: culprit or coincidence?
Skaper SD
Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
[TBL] [Abstract][Full Text] [Related]
57. Folic acid deficiency enhances abeta accumulation in APP/PS1 mice brain and decreases amyloid-associated miRNAs expression.
Liu H; Tian T; Qin S; Li W; Zhang X; Wang X; Gao Y; Huang G
J Nutr Biochem; 2015 Dec; 26(12):1502-8. PubMed ID: 26345540
[TBL] [Abstract][Full Text] [Related]
58. Cu and Zn interactions with Aβ peptides: consequence of coordination on aggregation and formation of neurotoxic soluble Aβ oligomers.
Rana M; Sharma AK
Metallomics; 2019 Jan; 11(1):64-84. PubMed ID: 30234208
[TBL] [Abstract][Full Text] [Related]
59. Clioquinol reduces zinc accumulation in neuritic plaques and inhibits the amyloidogenic pathway in AβPP/PS1 transgenic mouse brain.
Wang T; Wang CY; Shan ZY; Teng WP; Wang ZY
J Alzheimers Dis; 2012; 29(3):549-59. PubMed ID: 22269164
[TBL] [Abstract][Full Text] [Related]
60. Amyloid-beta metal interaction and metal chelation.
Cuajungco MP; Frederickson CJ; Bush AI
Subcell Biochem; 2005; 38():235-54. PubMed ID: 15709482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
